Skip to main content

Table 1 Baseline Demographics Mean (SD) or %

From: Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia

  Atorvastatin Combination
Age (years) 67.09 (9.668) 60.50 (9.561)
Male Sex 85 73.9
Coronary artery disease (%) 60 43.5
   Angina 40 39.1
   Previous Myocardial Infarction 35 13
   Previous PCI 40 21.7
   Previous CABG 15 21.7
Cerebrovascular Disease (%) 45 60.9
Peripheral Vascular Disease (%) 0 4.3
Lipid Parameters   
   Total Cholesterol (mmol/L) 5.69 (0.78) 5.98 (0.91)
   Low density lipoprotein (mmol/L) 3.58 (0.53) 3.91 (0.71)
   High density lipoprotein (mmol/L) 1.31 (0.28) 1.44 (0.20)
   Triglycerides (mmol/L) 1.75 (0.70) 1.35 (0.49)
   TC/HDL Ratio 4.49 (0.97) 4.20 (0.65)
Smoking Status (%)   
   Never Smoked 25 34.8
   Previous Smoker 70 52.2
   Current Smoker 5 13
Diabetes Mellitus (%) 10 30.4
Body Mass Index (kg/m2) 27.8 (3.50) 28.2 (5.43)
Weight (kg) 83.2 (12.80) 82.2 (17.82)
History of Hypertension (%) 60 65.2
Systolic Blood Pressure (mmHg) 128.4 (16.14) 121.4 (15.88)
Diastolic Blood Pressure (mmHg) 73.2 (8.57) 72.9 (11.68)
Mean hsCRP 3.62 (3.59) 2.91 (4.18)
Antithrombotic Therapy # (%) 19 (95) 23 (100)
Previous Lipid-Lowering Therapy # (%) 12 (60) 15 (65.2)
ACE-I/ATII Therapy # (%) 15 (75.0) 20 (87.0)